Geneos Wealth Management’s GoodRx Holdings GDRX Stock Holding History

Geneos Wealth Management’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.33K	Hold	679	–	–	﹤0.01%	2369
2025 Q4	$1.84K	Hold	679	–	–	﹤0.01%	2328
2025 Q3	$2.87K	Hold	679	–	–	﹤0.01%	2257
2025 Q2	$3.38K	Sell	679 -679	-50%	-$2.95K	﹤0.01%	2682
2025 Q1	$5.99K	Buy	1,358 +679	+100%	+$3.19K	﹤0.01%	2710
2024 Q4	$3.16K	Hold	679	–	–	﹤0.01%	2474
2024 Q3	$4.71K	Hold	679	–	–	﹤0.01%	2087
2024 Q2	$5.3K	Sell	679 -159	-19%	-$1.18K	﹤0.01%	1712
2024 Q1	$5.95K	Hold	838	–	–	﹤0.01%	1676
2023 Q4	$5.62K	Hold	838	–	–	﹤0.01%	1699
2023 Q3	$4.72K	Hold	838	–	–	﹤0.01%	1759
2023 Q2	$4.63K	Buy	838 +117	+16%	+$630	﹤0.01%	1758
2023 Q1	$4.51K	Buy	+721	New	+$4.02K	﹤0.01%	1759
2022 Q4	–	Sell	-6,500	Closed	-$30K	–	2049
2022 Q3	$30K	Buy	6,500 +6,175	+1,900%	+$38.9K	﹤0.01%	1197
2022 Q2	$2K	Hold	325	–	–	﹤0.01%	2384
2022 Q1	$6K	Sell	325 -300	-48%	-$6.88K	﹤0.01%	2272
2021 Q4	$20K	Hold	625	–	–	﹤0.01%	1888
2021 Q3	$27K	Sell	625 -2,325	-79%	-$84.4K	﹤0.01%	1769
2021 Q2	$99K	Hold	2,950	–	–	﹤0.01%	1168
2021 Q1	$118K	Buy	2,950 +620	+27%	+$27.9K	﹤0.01%	1220
2020 Q4	$87K	Buy	+2,330	New	+$107K	﹤0.01%	1199

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Geneos Wealth Management's GDRX Position: Q1 2026 in Review

Geneos Wealth Management held its GoodRx Holdings (GDRX) position steady in Q1 2026 at 679 shares worth $1.33K. The position accounts for ﹤0.01% of the portfolio, ranked #2369.

Geneos Wealth Management first reported a position in GDRX in Q4 2020 and has held it in 21 quarters since. The position peaked at $118K in Q1 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

Geneos Wealth Management held 679 shares of GoodRx Holdings worth $1.33K as of Q1 2026.
Geneos Wealth Management left its GoodRx Holdings share count unchanged in Q1 2026.
GoodRx Holdings made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #2369 holding.
Geneos Wealth Management first reported a position in GoodRx Holdings in Q4 2020 and has held it in 21 quarters since.
Geneos Wealth Management's GoodRx Holdings position peaked at $118K in Q1 2021.
174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.